Measurement of the melanin content by using B16 melanoma cells is generally applied to find novel skinwhitening agents. However, this measurement method using B16 melanoma cells has such disadvantages, as the time taken, its sensitivity, and troublesomeness. We therefore attempted in the present study to establish a reporter assay system by measuring the tyrosinase promoter activity to use for convenient, high-throughput screening of new melanogenesis inhibitors. We first confirmed the validity of this reporter assay system by using such known skin-whitening agents, as arbutin, sulforaphane, and theaflavin 3,3 0 -digallate. We then compared the effect of 56 compounds on the tyrosinase promoter activity to test this reporter assay system. Carnosol, and rottlerin strongly inhibited the tyrosinase promoter activity. Moreover, carnosol and rottlerin decreased melanin synthesis and tyrosinase expression in a dose-dependent manner when using B16 melanoma cells. These results indicate this new luciferase reported assay system to be an effective and convenient method for screening potential skin-whitening compounds.
Melanin is a biological pigment that forms the skin color and protects skin cells from ultra-violet (UV) irradiation. [1] [2] [3] Over-production and accumulation of melanin, however, may cause various skin disorders. The use of skin-whitening agents, particularly by women, has been growing in recent years. Research and development of melanogenesis inhibitors as agents for use in skin medications, and cosmetics has accordingly become more popular. The method usually used to find melanogenesis inhibitors is based on the measurement of melanin content by using B16 melanoma cells. However, this method suffers from such disadvantages as the time taken, its sensitivity, and troublesomeness; for example, the usual method to measure melanin production needs 48-96 h upon treating with the compound being tested. 2, 4, 5) Furthermore, the procedure requires culturing cells at the scale of at least a 35-mm dish or well in a 6-well plate, and involves such troublesome steps as cell counting and rendering melanin soluble. As an alternative method for screening skin-whitening agents, we developed a reporter assay system for measuring the promoter activity of the tyrosinase gene, the most important regulator of melanin synthesis.
We constructed for the present study, a luciferase reporter plasmid containing the 521-bp 5 0 -flanking sequence at the transcriptional start site of the mouse tyrosinase gene and transfected it into B16 mouse melanoma cells. The reporter assay system developed was first validated by using several known skin-whitening compounds. The system was then used to screen 56 different compounds in order to find new skin-whitening agents. The new compounds identified by this reporter assay were subsequently verified for their effects on decreasing melanin synthesis and tyrosinase expression in B16 melanoma cells.
Materials and Methods
Materials. Theophylline, arbutin, luteolin, (À)-epigallocatechin gallate (EGCG), (À)-epigallocatechin (EGC), kaempferol, galangin, resveratrol, curcumin, carnosic acid, cholesterol, cholic acid, 17-estradiol, lipoic acid, G418 disulfate salt, trypsin-EDTA, penicillinstreptomycin, and the trypsin inhibitor were from Sigma-Aldrich (St. Louis, MO, USA). Apigenin, daizdein, genistein, glycitein, quercetin dihydrate, theaflavin 3,3 0 -digallate, capsaicin, gamma-aminobutyric acid (GABA), 3-methoxyphenyl isothiocyanate, thymol, deoxycholic acid, and keto-deoxycholic acid were products from Wako Pure Chemicals (Osaka, Japan). Biochanin A, chrysin, diosmin, silymarin, cyanidin chloride, pelargonidin chloride, delphinidin chloride, carnosol, caffeine, sulforaphane, artemisinin, carveol, ginkgolide A, phytol, thymol, alizarin, danthron, ofloxacin, tiglic acid, cepharanthine, homoharringtonin, tropine, anisomycin, hexadecyl acetyl glycerol, kenpaullnone, rottlerin, tryphostin 1, benzylphosphonic acid, cantharidin, captopril, enalapril, and ketoconazole were from Funakoshi (Tokyo, Japan). Testosterone was a product from Nacalai Tesque (Kyoto, Japan), Dulbecco's modified Eagle's medium (DMEM) was from Nissui Pharmaceutical (Tokyo, Japan), fetal bovine serum (FBS) was from Nichirei Biosciences (Tokyo, Japan), the Bright-GloÔ luciferase assay system was from Promega (Madison, WI, USA), and HilyMax was from Dojindo Laboratories (Kumamoto, Japan).
Cell culture. B16 murine melanoma cells (JCRB0202), obtained from JCRB Cell Bank (Osaka, Japan), were routinely cultured in DMEM, supplemented with 10% FBS and penicillin-streptomycin (100 IU/ml, 50 mg/ml), in a humidified atmosphere containing 5% CO 2 at 37 C.
Construction of the reporter plasmid containing the mouse tyrosinase promoter. 552-bp DNA corresponding to the 5 0 -flanking region of mouse tyrosinase was amplified from mouse genomic DNA by a polymerase chain reaction (PCR) using the following primers: 5 0 -CCGCTCGAGGATGCATTGAAGCAGTTCACC-3 0 (À521/À501) and 5 0 -GAAGATCTTCCACAGACTTCTTTTCCAGCAAC-3 0 (þ31/ þ11). The nucleotide sequence of the PCR product was confirmed to be identical to that of the wild-type gene. The 552-bp PCR product was cloned into the Xho I-Bgl II sites of the pGL4 neo vector. The transcriptional initiation site was numbered þ1 according to the report of Shibata et al.
6)
Stable expression of the mouse tyrosinase promoter reporter gene in B16 cells. B16 mouse melanoma cells, which had been grown in 100-mm culture dishes, were transfected with 12 mg of the pGL4 neo plasmid harboring the cloned mouse tyrosinase promoter sequence, by the HilyMax reagent according to the standard procedure. After a 4-h incubation, the cells were passaged in the same culture medium supplemented with 1,000 mg/ml of G418 disulfate until distinct colonies appeared. After 4 weeks, the cells derived from individual clones were analyzed by using the luciferase reporter assay.
Measurement of the luciferase activity. B16 melanoma cells were incubated at a density of 3 Â 10 5 cells in a 35-mm dish. To confirm whether this reporter assay system was suitable for screening, the cells were treated for 24 h with different concentrations (10-1,000 mM) of theophylline and arbutin that are known to regulate tyrosinase expression. The cells were then treated with 10 mM of 51 compounds for 24 h. Five compounds at 10 mM (cepharanthine, homoharringtonin, anisomycin, hexadecyl acetyl glycerol, and rottlerin) each exerted a significant cytotoxic effect, and these compounds reduced the treatment concentration without significant cytotoxicity (Tables 1 and 2 ). The cells were washed after 24 h with phosphate-buffered saline (PBS), and lysed in the luciferase assay buffer. The cell lysate was centrifuged at 12;000 Â g for 2 min at 4 C. A 20 ml amount of each supernatant and 50 ml of the luciferase assay substrate were then added in a clear plastic tube, and the luciferase activity was measured by using a Luminescencer-PSN (Atto, Tokyo, Japan). The value was normalized with the protein concentration and is presented as the relative luciferase activity (%) against the control as 100%. The protein concentration of the supernatant was determined by using Lowry's assay method.
7)
Measurement of the melanin content. The melanin content was measured according to a previously established procedure, with slight modifications. 4) Briefly, the cells were incubated at a density of 3:0 Â 10 5 cells in a 35-mm dish. Treatment with the test compound began 24 h after seeding. After a 24-h treatment, the cells were washed with PBS, and detached with a trypsin-EDTA treatment. The cell suspension was centrifuged at 1;000 Â g for 5 min, the resulting cell pellet was resuspended in 1 ml of PBS, and 0.9 ml of the cell suspension was again centrifuged at 1;000 Â g for 5 min. The cell pellet was dissolved in 130 ml of 1 M NaOH, and the absorbance at 405 nm was determined and compared with an untreated control.
Western blot analysis. Cells that had been treated for 24 h with theophylline or arbutin were lysed in a 50 mM sodium phosphate buffer (pH 6.8) containing 1% Triton X-100 and protease inhibitors. The proteins in the cell lysate were separated by 7.5% SDS-polyacrylamide gel electrophoresis and blotted on to a PVDF membrane. The blotted membrane was treated for 1 h with 5% non-fat milk in PBS containing 0.05% Tween 20. Subsequently, in the case of tyrosinase, the membrane was incubated for 1 h with the anti-tyrosinase antibody (1:1,000), and further incubated for 1 h with the anti-goat antibody conjugated with horseradish peroxidase (1:5,000). In the case ofactin, the membrane was incubated for 1 h with the anti--actin antibody (1:3,000) and further incubated for 1 h with the anti-mouse antibody conjugated with horseradish peroxidase (1:5,000). The signals were visualized by the enhanced chemiluminescence reagent (ECL Plus) with a ChemiDoc XRS image analyzer (Bio-Rad, Hercules, CA, USA).
Cell viability assay. Cell viability was assayed by using the trypan blue dye exclusion method. 4) After incubating the cells with a test compound for 24 h, the culture medium was removed, and the cells were detached with trypsin-EDTA from the dish. To 100 ml of the cell suspension was added 100 ml of 0.4% trypan blue in the well of a 96-well plate. The viable cells were counted by using an inverted microscope.
Statistical analysis. Data are expressed as the mean AE SD, and were analyzed by Dunnett's test to evaluate significant differences of the means compared with the control.
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Results
Stable expression of the mouse tyrosinase promoter reporter gene in B16 cells B16 cells transfected with the mouse tyrosinase promoter-containing luciferase reporter plasmid construct were selected by using G418. Fifteen independent clones were chosen and individually seeded in 35-mm dishes for further selection. Each clone was seeded to allow the cells to achieve 80-90% confluence, and then measured for luciferase activity. Of the fifteen clones, only one, designated B16-luc, showed strong tyrosinase promoter activity, and was expanded and used in the subsequent studies.
Effects of arbutin and theophylline on tyrosinase promoter activity and melanogenesis using B16 melanoma cells
Transfected B16 melanoma cells were exposed to arbutin and theophylline that are known to regulate tyrosinase expression. Arbutin is the representative compound that inhibits melanin synthesis by suppressing tyrosinase expression. 9) On the other hand, theophylline is well known to induce melanin synthesis by stimulating tyrosinase expression. 10) In the presence of 10, 50, 100, 500, and 1,000 mM of arbutin, the tyrosinase promoter activity was 105:4 AE 7:1%, 81:9 AE 4:6%, 77:8 AE 2:2%, 46:2 AE 7:4%, and 38:5 AE 10:0% as compared with the untreated control cells, while the melanin content was 92:9 AE 5:9%, 82:1 AE 7:1%, 76:2 AE 0:9%, 67:8 AE 5:4%, and 67:4 AE 11:3% as compared with the control cells (Fig. 1A) .
In the presence of 10, 50, 100, 500, and 1,000 mM of theophylline, the promoter activity using B16-luc melanoma cells was 114:0 AE 25:0%, 134:9 AE 11:6%, 151:4 AE 10:9%, 236:0 AE 29:1%, and 296:8 AE 58:9% as compared with the control cells, while the melanin content was 113:0 AE 10:4%, 128:9 AE 10:2%, 146:6 AE 6:4%, 161:4 AE 10:8%, and 188:0 AE 25:9% as compared with the control cells (Fig. 1B) .
Effects of sulforaphane, theaflavin 3,3
0 -digallate, carnosic acid and genistein on tyrosinase promoter activity and melanogenesis using B16 melanoma cells Sulforaphane, theaflavin 3,3 0 -digallate, and carnosic acid, which have been reported to inhibit melanogenesis, also decreased the tyrosinase promoter activity in a dose-dependent manner ( Fig. 2A, B, and C) . 5, 11, 12) With 10 mM of sulforaphane, theaflavin 3,3 0 -digallate, and carnosic acid, the tyrosinase promoter activity was 66:4 AE 3:9%, 73:5 AE 10:3%, and 69:9 AE 6:0%, while the melanin content was 84:0 AE 8:3%, 79:8 AE 5:1%, and 81:4 AE 4:1%.
Genistein was known to stimulate melanogenesis.
13)
With 10 mM of genistein, the tyrosinase promoter activity was 292:5 AE 60:1% and melanin content was 129:0 AE 4:0% (Fig. 2D ). In the case of being treated with 10 mM genistein for 96 h, the melanin content was more than 1.5 times that of the control cells (data not shown). These results clearly indicate that, similar to the findings previously reported, 5,9-13) the sensitivity of the tyrosinase promoter assay tended to be higher than measuring the melanin content by using B16 cells. The luciferase reporter assay system built into the B16-luc melanoma cells, could therefore, be used as a tool for screening compounds with a regulating effect on the tyrosinase promoter activity.
Screening potential skin-whitening compounds with the mouse tyrosinase promoter reporter assay
We compared the effects on the tyrosinase promoter activity of 56 compounds, including flavonoids, quinones, terpenoids, alkaloids, isothiocyanates, and steroids. The data obtained showed that 10 of them, (apigenin, chrysin, luteolin, biochanin A, daizdein, genistein, galangin, resveratrol, homoharringtonin, and kenpaullnone) increased the luciferase activity by more than twice as compared with the untreated control cells (Tables 1 and 2) . Interestingly, flavones, isoflavones, and flavonols increased the tyrosinase promoter activity, whereas catechins and anthocyanidins had no effect. These results suggest that the structural backbone, but not the functional group, played a more important role in affecting the tyrosinase promoter activity.
In contrast to the flavonoids, carnosol, and rottlerin strongly inhibited the tyrosinase promoter activity. With 1, 5, and 10 mM of carnosol, the tyrosinase promoter activity was 86:3 AE 3:3%, 58:3 AE 18:2%, and 38:8 AE 8:8% (Fig. 3A) . The inhibitory effect of 10 mM carnosol on the tyrosinase promoter activity was at a level equivalent to that of 1,000 mM arbutin. With 0.5 mM of rottlerin, the activity was 87:6 AE 4:9%, but there was no significant difference between 0.5 mM rottlerin and the untreated control. The luciferase activity of 1 mM of rottlerin was 64:7 AE 9:0% (Fig. 3B) . At concentrations higher than 1 mM, rottlerin exerted a significant cytotoxic effect, although the tyrosinase promoter activity was decreased in a dose-dependent manner (data not shown).
Effects of carnosol and rottlerin on melanin production and tyrosinase expression in B16 melanoma cells With 1, 5, and 10 mM of carnosol, the melanin content was 85:7 AE 4:4%, 63:8 AE 4:6%, and 52:3 AE 3:9% (Fig. 4A) , while the tyrosinase expression was also decreased in a dose-dependent manner (Fig. 4C) . Carnosol inhibited melanogenesis much more strongly than such other reported compounds as arbutin and, sulforaphane. With 0.05, 0.1, and 0.5 mM of rottlerin, the melanin content was 88:1 AE 11:8%, 84:6 AE 4:5%, and 75:7 AE 5:6% (Fig. 4B) , while the tyrosinase expression was also decreased in a dose-dependent manner Data shown are presented as the mean AE SD derived from three determinations.
( Fig. 4D) . Rottlerin decreased the melanin production and tyrosinase expression at a submicromolar concentration. This reporter assay system enabled us to easily find two new anti-melanogenic compounds.
Discussion
Since the over-production and accumulation of melanin might occur in melasma, freckles, and other forms of melanin hyper-pigmentation, melanogenesis inhibitors have been developed as agents for use in medications and cosmetics; [1] [2] [3] for example, such tyrosinase inhibitors as arbutin, hydroquinone, and ellagic acid have been included in some cosmetic products. 14, 15) Although we could also find sulforaphane with the usual method by measuring the melanin content using B16 melanoma cells, 5) this method took a long time and was troublesome for high-throughput screening. We developed in this study a new and more effective screening method to search for skin-whitening agents.
Tyrosinase, which catalyzes the rate-limiting steps of melanin biosynthesis, is the key enzyme in melanogenesis. It has been reported that the mouse tyrosinase core promoter region contained two important cis elements, a 10-bp (M-box) and a 6-bp (E-box) containing the sequence -CATGTG-and 270-bp 5 0 -flanking sequence of the transcriptional starting site that encompassed the above-mentioned core sequences (M-box and E-box), that were sufficient to direct pigment cell-specific tyrosinase expression in B16 melanoma cells. 16, 17) We therefore constructed a luciferase reporter plasmid containing the 521-bp 5 0 -flanking sequence at the transcriptional starting site of the mouse tyrosinase gene. We confirmed the validity of this reporter assay system with such anti-melanogenic compounds as arbutin, sulforaphane, and theaflavin 3,3 0 -digallate that decreased tyrosinase expression. All these compounds decreased the tyrosinase promoter activity. The results for the tyrosinase promoter activity and melanin production were strongly correlated. Moreover, they were similar to the results for theophylline and genistein that induced melanogenesis. The treatment time for compounds with this reporter assay system was 24 h, this being much shorter than the time needed for the usual melanin production assay using B16 melanoma cells. 2, 4, 5) This reporter assay system was more highly responsive than the usual method and proved to be suitable for a high-throughput screening assay. We then compared the effect on tyrosinase promoter activity of 56 compounds, subsequently finding with this reporter assay system that carnosol, and rottlerin strongly inhibited the tyrosinase promoter activity. Carnosol, the integral constituent of a Rosmarinus officinalis extract, is a phenolic diterpene known to have antioxidative and anti-inflammatory activities. 18) Carnosic acid can be converted to carnosol by oxidation. Rottlerin, a natural product purified from Mollotus phillippinensis, has been used as a protein kinase C-(PKC-)-selective inhibitor. 19, 20) In fact, carnosol and rottlerin were each found to be capable of reducing melanogenesis and tyrosinase expression at a lower concentration than that of arbutin. These results indicate that carnosol and rottlerin may be suitable as skin-whitening agents for cosmetics and also as functional food supplements.
However, this reporter assay system had the disadvantage that is not capable of finding the compounds directly inhibiting tyrosinase enzyme activity. In addition, it is unclear whether these potential skin-whitening compounds found would be effective for human skinwhitening in vivo.
In summary, the luciferase reporter system developed in this study, which is simpler to use than the usual melanin production assay using B16 cells, may serve as an efficient high-throughput screening method to find novel skin-whitening agents.
